| Dr Cassandra A Mahan-richards, MD | |
|
11980 Mount Vernon Ave, Grand Terrace, CA 92313-5172 | |
| (909) 864-1097 | |
| (951) 225-6879 |
| Full Name | Dr Cassandra A Mahan-richards |
|---|---|
| Gender | Female |
| Speciality | Allergy & Immunology - Allergy |
| Location | 11980 Mount Vernon Ave, Grand Terrace, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093767782 | NPI | - | NPPES |
| MD60286895 | Other | WA | WASHINGTON STATE LICENSE |
| 00G646250 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | G53986 (California) | Secondary |
| 207KA0200X | Allergy & Immunology - Allergy | MD60286895 (Washington) | Primary |
| Entity Name | Rockwood Clinic Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417953787 PECOS PAC ID: 8527976513 Enrollment ID: O20031117000912 |
News Archive
Resistance to chemotherapy is a major problem for those suffering from ovarian cancer-a problem that prevents a cure from a disease dubbed the "silent killer." University of Georgia researchers are giving patients new hope with recent findings that help pinpoint the mechanisms causing chemoresistance.
The results of a world-first controlled trial of dialysis start-time in patients with Stage V chronic kidney disease is set to have major impact on the cost and infrastructure of chronic kidney disease (CKD) treatment and dialysis services.
For the first time, greenhouse gas data are accessed easily on a new CSIRO website. The site shows the levels of greenhouse gases measured in the Southern Hemisphere atmosphere for the past 35 years.
Results of a subanalysis from the FAIR-HF study demonstrate that correcting iron deficiency with Ferinject (ferric carboxymaltose) can improve renal function in chronic heart failure patients. Ferinject is an intravenous iron product used to treat iron deficiency and iron deficiency anaemia.
› Verified 9 days ago
| Entity Name | Advanced Allergy And Asthma, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841429743 PECOS PAC ID: 3274662853 Enrollment ID: O20100519000658 |
News Archive
Resistance to chemotherapy is a major problem for those suffering from ovarian cancer-a problem that prevents a cure from a disease dubbed the "silent killer." University of Georgia researchers are giving patients new hope with recent findings that help pinpoint the mechanisms causing chemoresistance.
The results of a world-first controlled trial of dialysis start-time in patients with Stage V chronic kidney disease is set to have major impact on the cost and infrastructure of chronic kidney disease (CKD) treatment and dialysis services.
For the first time, greenhouse gas data are accessed easily on a new CSIRO website. The site shows the levels of greenhouse gases measured in the Southern Hemisphere atmosphere for the past 35 years.
Results of a subanalysis from the FAIR-HF study demonstrate that correcting iron deficiency with Ferinject (ferric carboxymaltose) can improve renal function in chronic heart failure patients. Ferinject is an intravenous iron product used to treat iron deficiency and iron deficiency anaemia.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cassandra A Mahan-richards, MD Po Box 3649, Spokane, WA 99220-3649 Ph: () - | Dr Cassandra A Mahan-richards, MD 11980 Mount Vernon Ave, Grand Terrace, CA 92313-5172 Ph: (909) 864-1097 |
News Archive
Resistance to chemotherapy is a major problem for those suffering from ovarian cancer-a problem that prevents a cure from a disease dubbed the "silent killer." University of Georgia researchers are giving patients new hope with recent findings that help pinpoint the mechanisms causing chemoresistance.
The results of a world-first controlled trial of dialysis start-time in patients with Stage V chronic kidney disease is set to have major impact on the cost and infrastructure of chronic kidney disease (CKD) treatment and dialysis services.
For the first time, greenhouse gas data are accessed easily on a new CSIRO website. The site shows the levels of greenhouse gases measured in the Southern Hemisphere atmosphere for the past 35 years.
Results of a subanalysis from the FAIR-HF study demonstrate that correcting iron deficiency with Ferinject (ferric carboxymaltose) can improve renal function in chronic heart failure patients. Ferinject is an intravenous iron product used to treat iron deficiency and iron deficiency anaemia.
› Verified 9 days ago